Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction
Completed · Phase 3 · Has a placebo group
Conditions studied: Heart Failure
In brief
The purpose of this study is to determine if treatment with omecamtiv mecarbil when added to standard of care is well tolerated and superior to placebo in reducing the risk of cardiovascular death or heart failure events in adults with chronic heart failure with reduced ejection fraction (HFrEF).
Key facts
- Study ID
- NCT02929329
- Run by
- Cytokinetics
- People needed
- 8256
- Starts
- 2017-01-06
- Expected to finish
- 2020-09-14
- Last updated by the study team
- 2021-11-05
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Birmingham, Alabama, United States
- Research Site — Birmingham, Alabama, United States
- Research Site — Fort Payne, Alabama, United States
- Research Site — Huntsville, Alabama, United States
- Research Site — Mobile, Alabama, United States
- Research Site — Scottsboro, Alabama, United States
- Research Site — Tuscumbia, Alabama, United States
- Research Site — Gilbert, Arizona, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Tucson, Arizona, United States
- Research Site — Tucson, Arizona, United States
- Research Site — Jonesboro, Arkansas, United States
- Research Site — Little Rock, Arkansas, United States
- Research Site — Anaheim, California, United States
- Research Site — Beverly Hills, California, United States
- Research Site — Burbank, California, United States
- Research Site — Carmichael, California, United States
- Research Site — Fresno, California, United States
- Research Site — Huntington Beach, California, United States
- Research Site — Loma Linda, California, United States
- Research Site — Long Beach, California, United States
- Research Site — Long Beach, California, United States
- Research Site — Los Alamitos, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.